BNP Paribas Financial Markets
YDES

BNP Paribas Financial Markets’s YD Bio Ltd YDES Stock Holding History

BNP Paribas Financial Markets’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-90
Closed -$1.75K – 6034
2025
Q3 		$1.75K Buy
+90
New +$1.56K ﹤0.01% 5182

Other funds holding YDES

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BNP Paribas Financial Markets's YDES Position: Q4 2025 in Review

BNP Paribas Financial Markets sold out of YD Bio Ltd (YDES) in Q4 2025, closing a stake of 90 shares — an estimated $1.75K sold.

BNP Paribas Financial Markets first reported a position in YDES in Q3 2025 and held it in 1 quarter. The position peaked at $1.75K in Q3 2025. 10 funds tracked by Wall St. Rank hold YDES as of Q4 2025.

  • BNP Paribas Financial Markets reported no remaining YD Bio Ltd position as of Q4 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 90 YD Bio Ltd shares in Q4 2025, an estimated $1.75K.
  • BNP Paribas Financial Markets first reported a position in YD Bio Ltd in Q3 2025 and held it in 1 quarter.
  • BNP Paribas Financial Markets's YD Bio Ltd position peaked at $1.75K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held YD Bio Ltd as of Q4 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.